Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
Botulinum neurotoxins (BoNTs) exhibit extraordinary potency due to their exquisite neurospecificity, which is achieved by dual binding to complex polysialo-gangliosides and synaptic vesicle proteins. The luminal domain 4 (LD4) of the three synaptic vesicle glycoprotein 2 isoforms, SV2A‐C, identified...
Main Authors: | Jasmin Weisemann, Daniel Stern, Stefan Mahrhold, Brigitte G. Dorner, Andreas Rummel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-05-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/8/5/154 |
Similar Items
-
Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E
by: Geoffrey Masuyer, et al.
Published: (2021-08-01) -
Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A–F Employing Taguchi Design-of-Experiments
by: Laura von Berg, et al.
Published: (2019-10-01) -
Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics
by: Jonathan R. Davies, et al.
Published: (2018-10-01) -
Emerging Opportunities for Serotypes of Botulinum Neurotoxins
by: John Tapia-Núñez, et al.
Published: (2012-11-01) -
Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
by: Bernard Poulain, et al.
Published: (2019-01-01)